Navigation Links
Oramed Pharmaceuticals Announces Successful Phase 2A Clinical Trial of its Oral Insulin Capsule
Date:8/6/2008

The Trial Demonstrated the Safety and Efficacy of the ORMD 0801- Oral

Insulin Capsule

JERUSALEM, Israel, August 6 /PRNewswire-FirstCall/ -- Oramed Pharmaceuticals, Inc. (OTCBB: ORMP)(http://www.oramed.com), a developer of oral delivery systems, announced today successful results from the clinical trial of its oral insulin capsule, ORMD 0801. The trial demonstrated that the product had a good safety profile and was well tolerated and effective in lowering blood glucose levels in patients with type 2 diabetes.

The study was conducted at Hadassah University Medical Center in Jerusalem and was a continuation of the successful Phase 1B trials that Oramed completed earlier this year.

This trial was the first to expose patients with type 2 diabetes to ORMD 0801 and its primary goals were to assess the safety, tolerability and pharmcodynamic effects in these patients.

ORMD 0801 was well tolerated by all patients and had a good safety profile; no serious adverse events were encountered throughout the study. In 6 of the 9 subjects analyzed, statistically significant reductions in glucose as well as C-peptide were observed.

"We are pleased with the results from the Phase 2A trial as they showed that ORMD 0801 was effective and there were no safety issues," said Oramed's Chief Scientist, Dr. Miriam Kidron. "We look forward to our next phase of testing and taking the next steps towards making an oral insulin capsule a reality for millions of diabetics around the world."

About Oramed Pharmaceuticals

Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs and vaccines presently delivered via injection. Oramed is seeking to revolutionize the treatment of diabetes through its patented flagship product, an orally ingestible insulin capsule currently in phase 2 clinical trials. Established in 2006, Oramed's te
'/>"/>

SOURCE Oramed Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Oramed Pharmaceuticals to Hold Conference Call on August 6 to Present Results of Phase 2A Oral Insulin Capsule Clinical Trials
2. Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences
3. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
4. Idenix Pharmaceuticals Advances HCV Discovery Program to Clinic
5. Celator Pharmaceuticals Raises Series C Financing in Excess of $22.5 Million
6. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008
7. Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer
8. Meditrina Pharmaceuticals, Inc. Opens Investigational New Drug (IND) Application for Phase IIb Clinical Trial With MPI-676 in Endometriosis
9. BioNumerik Pharmaceuticals Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept(TM) Clinical Trial
10. Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease
11. MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...v.25/PRNewswire-USNewswire/--RemediumTechnologiesI...opsseverebleeding,wonfirstprizeand$10,000intheMost...allenge2009,companyofficialsannouncetoday. ,, S...medium,steampitchedtheirinventionattheGSCSecurityS..., Remedium( www.remediumtechnologies.com )isdeve...
(Date:11/25/2009)...ewswire/--Reportlinker.comannouncesthatanewmarketr...mmographyEquipment-AGlobalMarketPerspective ,...y-Equipment---A-Global-Market-Perspective.html ,...swellasdevelopingnationsisaprincipalfactorinfluenc...gawarenessaboutbreastcancerhasallowedwomentocomefo...
(Date:11/25/2009)...v.25/PRNewswire/--CempraPharmaceuticalsInc.todayan...xecutiveofficer,willpresentatthePiperJaffray21stAn...09,atTheNewYorkPalaceHotelinNewYorkCity.Dr.Fernand...ibioticclinicalprogramsforthetreatmentofdrug-resis...maceuticals ,, Foundedin2006,CempraPharmaceuti...
Breaking Medicine Technology:Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Analysis of Copernicus putative remains support identity 9138 1Analysis of Copernicus putative remains support identity 9138 2When it comes to brain damage blankets take the place of drugs 9135 1Journal of Vascular and Interventional Radiology 3A New patient radiation safety guidelines 9132 1Journal of Vascular and Interventional Radiology 3A New patient radiation safety guidelines 9132 2Journal of Vascular and Interventional Radiology 3A New patient radiation safety guidelines 9132 3
...Cryst,Pharmaceuticals, Inc. (Nasdaq: BCRX ) today...ing forodesine HCl, the Company,s lead anti-cancer...ukemias and lymphomas., Madeline Duvic, M.D., Dep...D. Anderson Cancer Center presented interim data f...ne HCl in the treatment of subjects,with refractor...
...proved for the Treatment of PKU, NOVATO, Calif., ...SWX: BMRN) announced today that the U.S.,Food and ...proval for,Kuvan(TM) (sapropterin dihydrochloride)... for the treatment of phenylketonuria (PKU). Shipm...orrow, and BioMarin will begin,promotion of Kuvan ...
Other Medicine Technology:Data Presented at 2007 ASH Meeting Demonstrate Activity of Forodesine HCl as a Single Agent or in Combination With Bendamustine in Certain Types of Leukemia and Lymphoma 2Data Presented at 2007 ASH Meeting Demonstrate Activity of Forodesine HCl as a Single Agent or in Combination With Bendamustine in Certain Types of Leukemia and Lymphoma 3Data Presented at 2007 ASH Meeting Demonstrate Activity of Forodesine HCl as a Single Agent or in Combination With Bendamustine in Certain Types of Leukemia and Lymphoma 4BioMarin Announces FDA Approval for Kuvan 2BioMarin Announces FDA Approval for Kuvan 3BioMarin Announces FDA Approval for Kuvan 4BioMarin Announces FDA Approval for Kuvan 5BioMarin Announces FDA Approval for Kuvan 6BioMarin Announces FDA Approval for Kuvan 7BioMarin Announces FDA Approval for Kuvan 8
(Date:11/27/2009)... Multi-purpose bilingual coloring books de... by the business community to educate - inform par...rom Safety issues to Dinosuars to ABC,S and a host... Louis, MO (PRWEB) November 27, 2009 -- Today&rsqu...oys to keep them busy any hour of the day, but one...
(Date:11/26/2009)...years, the number of Americans living with diabete... in 2009 to 44.1 million in 2034. Over the same pe...ing from $113 billion to $336 billion, even with n...rs based at the University of Chicago report in th...r of those with diabetes covered by Medicare will ...
(Date:11/26/2009)... Dr. David Kim of the Live Life Again Cent...llas , is one of a growing number of physicians wh...ng sites to connect with individuals who are inter...orbid obesity. Dr. Kim is utilizing Facebook to sh...his practice with the community. , ...
(Date:11/25/2009)...Y,Mo.,Nov.25/PRNewswire/--TheBartleHallConventionC...lcliniconDec.9-10,whenKansasCityhoststhelatestinas... "Thisfreecliniceventhasthepotentialtobethebiggest...oneandbeheldonweekdaysinsteadofoveraweekend,"Sheri...nicandpresidentoftheNationalAssociationofFreeClini...
(Date:11/25/2009)...ING,Md.,Nov.25/PRNewswire-USNewswire/--Anarticleby...EvaluationandResearch,titled"ADifficultBalance-Pai...26,2009issueofTheNewEnglandJournalofMedicine. ,...824/FDALOGO ) ,, Inthearticle,Woodcockdiscusses...ationforthosewhoneeditandmanagingtherisksposedbyva...
Breaking Medicine News(10 mins):Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Kansas City Prepares for Largest Free Health Clinic 2
...rley Industries,Inc. (Nasdaq: HRLY ) announced to...lley, passed away after a lengthy illness on Febru...s, Inc. in 1998 as Director of,Investor Relations....d Executive Vice President before being named,Herl...
...The Generic Pharmaceutical,Association (GPhA) Boar...y,elected Executive Committee and announced the el...North America, to serve as its Chairman for 2008-,...cal companies in the world and is the leading gene...
...Experts to Educate Americans about the,Impact of B... 12 Select Comfort Corporation,(Nasdaq: SCSS ), ...he SLEEP,NUMBER(R) bed, has hand-picked five inter... lives through better sleep,and a better bed., "P...
... surgery procedures for a minimally invasive,surgi... Feb. 12 Atrial fibrillation, a type,of abnormal ...s and upwards,of 6 million people in the United St...ntly required a large,incision in the chest, putti...
... Clinical Information,Network, Inc., announces the...e-art, videoconferencing network established speci...allows physicians to conduct face-to-face onscreen...s,including sales representatives of pharmaceutica...
...inica Biblica Hospital, a,general hospital in San ...,Commission International (JCI) accreditation, has... of overseas hospitals, Companion Global,Healthcar...mpanion Global Healthcare,clients at pre-negotiate...
Other Medicine News:Health News:Herley Industries Announces the Passing of Its Former President 2Health News:GPhA Announces 2008-2009 Executive Committee; Teva North America's Bill Marth Elected as Chairman of the Board 2Health News:Select Comfort Creates Sleep Number Quality of Life Advisory Board to Improve Lives, Enhance Well-Being 2Health News:Select Comfort Creates Sleep Number Quality of Life Advisory Board to Improve Lives, Enhance Well-Being 3Health News:Northwestern Memorial's Heart Center Pioneers Minimally Invasive Surgery That Corrects Irregular Heart Beat 2Health News:Northwestern Memorial's Heart Center Pioneers Minimally Invasive Surgery That Corrects Irregular Heart Beat 3Health News:Clinical InfoNet Goes Live 2Health News:Clinical InfoNet Goes Live 3Health News:Companion Global Healthcare Adds Hospital in Costa Rica to Overseas Network 2
...urgical Access ...unlike any trocar system you've ...actually four systems in one designed to be versa...ve to all of your needs., ,By offering options in...OnePort™ can effectively address the individ...
...urgical Access ...unlike any trocar system you've ...actually four systems in one designed to be versa...ve to all of your needs., ,By offering options in...OnePort™ can effectively address the individ...
...urgical Access ...unlike any trocar system you've ...actually four systems in one designed to be versa...ve to all of your needs., ,By offering options in...OnePort™ can effectively address the individ...
FLEXIPATH Flexible Surgical Trocar Paks
Medicine Products: